European Commission Decision Reliance Procedure (ECDRP) extension

13/02/2023

The ECDRP has been extended to 31 December 2023. From 1 January 2024, a new international recognition framework will be in place.

Read the press release from Medicines and Healthcare products Regulatory Agency published on 24 January 2023.

lsgilbert

Voir tous les articles

---

OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (13 février 2023). European Commission Decision Reliance Procedure (ECDRP) extension. ELSIBI. Consulté le 15 octobre 2026 à l’adresse https://doi.org/10.58079/o68n

---

Étiquettes : Access to medicinesBrexitEuropean CommissionMedicinesMHRANational medicines agencyUK

• Article suivant UK landmark genomic partnership with Thailand to unite against health threats
• Article précédent UK to introduce first-of-its-kind framework to make it easier to manufacture innovative medicines at the point of care

Vous aimerez aussi...

• 0

  Annual report from EMA to the Commission on the application of the Regulation on medicines for children

  14/03/2022

   par lsgilbert

   par lsgilbert · Published 14/03/2022 · Last modified 12/09/2022

• 0

  Data on cross-border patient healthcare following Directive 2011/24/EU for reference year 2024

  26/05/2026

   par lsgilbert

   par lsgilbert · Published 26/05/2026

• 0

  EMA – Update of the Questions & answers – Practical arrangements on the companion diagnostics consultation procedure to the European Medicines Agency by notified bodies

  19/05/2025

   par vroby

   par vroby · Published 19/05/2025